Managing Adverse Events Related to SGLT2 Inhibitors: What a Pharmacist Needs to Know to Optimize Clinical Outcomes

Pharmacy Times, April 2015 Respiratory Health, Volume 81, Issue 4


Daphne E. Smith Marsh, PharmD, CDE

Clinical Assistant Professor

Department of Pharmacy Practice

University of Illinois at Chicago

Clinical Pharmacist

Ambulatory Pharmacy Services

University of Illinois at Chicago

Chicago, Illinois

Educational Objectives:

After completing this continuing education program, the participant will be able to:

  • Identify which patients are most likely to benefit from SGLT2 inhibitor therapy.
  • List common adverse effects of SGLT2 inhibitors.
  • Review the counseling and monitoring needed to identify and minimize the adverse effects associated with the SGLT2 inhibitors in the treatment of type 2 diabetes mellitus.

Target audience:


Type of activity:


Release date:

April 7, 2015

Expiration date:

April 7, 2017

Estimated time to complete activity

: 2.0 hours



Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

This activity is approved for 2.0 contact hours (0.20 CEUs) under the ACPE universal activity number 0290-0000-15-029-H01-P. The activity is available for CE credit through April 7, 2017.